Talk Infusion: MTF Enrollment for Part D Participants & Advocacy Updates

Are you ready for the upcoming Medicare changes?

As CMS prepares to implement maximum fair price (MFP) for negotiated drugs in 2026, all providers must prepare now to comply with new mandates, regardless of whether they plan to dispense MFP drugs.

Join NHIA as we cover critical updates to ensure ongoing participation in Part D Prescription Drugs Plans, including how to prepare to enroll with the Medicare Transactions Facilitator (MTF) Data Module (starting June 2025).

We will also provide an update on NHIA’s latest advocacy efforts, including changes to the 2025 Preserving Patient Access to Home Infusion Act, which has several new provisions to support providers and improve the chance of passage. The updated legislation would now expand home infusion coverage for IV anti-infectives, create a 5-year transitional period and bundle the payment for disposable supplies.

Connie Sullivan

President & CEO

National Home Infusion Association

Connie Sullivan, B.S.Pharm, is the President and CEO of NHIA. Sullivan has over 25 years of infusion industry leadership, management, and clinical practice experience. Sullivan is responsible for NHIA’s advocacy initiatives and developing resources that support the infusion industry to foster innovation and promote the delivery of high-quality care. Sullivan also oversees the National Home Infusion Foundation, a 501c3 devoted to infusion research and developing future leaders. Sullivan is a member of the United States Pharmacopeia (USP) Sterile Compounding Expert Committee and currently Chairs the <797> Subcommittee. Sullivan earned her pharmacy degree from The Ohio State University in 1994.

NHIA Requires planners, faculty, and others who affect the content of this activity to disclose all financial relationships they have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to policy.

Connie Sullivan has no relevant financial relationships with ineligible companies to disclose.

Bill Noyes

Sr VP of Reimbursement Policy

NHIA

Bill Noyes is the Senior Vice President of Reimbursement Policy at the National Home Infusion Association (NHIA). He joined NHIA in 2012 as Vice President of Health Information Policy, focusing on reimbursement and regulatory issues affecting providers' ability to do business and collect payment for their services. Noyes sits on four Medicare Contractor Advisory Councils and is the liaison to NHIA's reimbursement-focused committees. He also works closely with the NHIA government relations team to gain more meaningful Medicare coverage for home infusion. He served as Interim CEO of the associaiton from July 2018 to November 2018. Prior to joining NHIA, Noyes spent 20 years as Vice President of Operations for a multi-state home infusion provider where he was responsible for purchasing, distribution, facilities, revenue cycle management, and pharmacy operations.

Bill Noyes has no relevant financial relationships with ineligible companies to disclose.